Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.

Abstract:

:The transcription factor CCAAT enhancer binding protein α (C/EBPα) is a master regulator in granulopoiesis and is frequently disrupted in acute myeloid leukemia (AML). We have previously shown that C/EBPα exerts its effects by regulating microRNAs (miRs) such as miR-223 and miR-34a. Here, we confirm miR-30c as a novel important target of C/EBPα during granulopoiesis. Thus, wild-type C/EBPα-p42 directly upregulates miR-30c expression, whereas C/EBPα-p30, found in AML, does not. miR-30c is downregulated in AML, especially in normal karyotype AML patients with CEBPA mutations. An induced C/EBPα knockout in mice leads to a significant downregulation of miR-30c expression in bone marrow cells. We identified NOTCH1 as a direct target of miR-30c. Finally, a block of miR-30c prevents C/EBPα-induced downregulation of Notch1 protein and leads to a reduced CD11b expression in myeloid differentiation. Our study presents the first evidence that C/EBPα, miR-30c, and Notch1 together play a critical role in granulocytic differentiation and AML, and particularly in AML with CEBPA mutations. These data reveal the importance of deregulated miRNA expression in leukemia and may provide novel biomarkers and therapeutic targets in AML.

journal_name

Blood

journal_title

Blood

authors

Katzerke C,Madan V,Gerloff D,Bräuer-Hartmann D,Hartmann JU,Wurm AA,Müller-Tidow C,Schnittger S,Tenen DG,Niederwieser D,Behre G

doi

10.1182/blood-2012-12-472183

subject

Has Abstract

pub_date

2013-10-03 00:00:00

pages

2433-42

issue

14

eissn

0006-4971

issn

1528-0020

pii

blood-2012-12-472183

journal_volume

122

pub_type

杂志文章

相关文献

BLOOD文献大全
  • An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1).

    abstract::A variant subline (KG-1a) of the human acute myelogenous leukemia (AML) cell line (KG-1) has been isolated. The cells retain the same constitutive markers as the parent line, including HLA antigens, isoenzymes, and karyotype. The cells from the subline are morphologically and histochemically undifferentiated blast cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Koeffler HP,Billing R,Lusis AJ,Sparkes R,Golde DW

    更新日期:1980-08-01 00:00:00

  • Molecular and cellular effects of antisickling concentrations of alkylureas.

    abstract::Alkylureas are capable of inhibiting sickling in vitro and the gelation of solutions of hemoglobin S at concentrations between 0.05 and 0.1 M with increasing effectiveness that is directly proportional to the length of the alkyl chain (butyl greater than propyl greater than ethyl greater than methyl). 6The inhibitory ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Elbaum D,Roth EF Jr,Neumann G,Jaffé ER,Bookchin RM,Nagel RL

    更新日期:1976-08-01 00:00:00

  • Growth inhibition of a human myeloma cell line by all-trans retinoic acid is not mediated through downregulation of interleukin-6 receptors but through upregulation of p21(WAF1).

    abstract::All-trans retinoic acid (ATRA) has previously been shown to inhibit the growth of OPM-2 human myeloma cells. The growth inhibition was postulated to result from a transcriptional downregulation of interleukin-6 receptor alpha (IL-6Ralpha) with IL-6Rbeta (gp130) unaffected. To formally test this hypothesis, an expressi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chen YH,Lavelle D,DeSimone J,Uddin S,Platanias LC,Hankewych M

    更新日期:1999-07-01 00:00:00

  • Evaluation of published single nucleotide polymorphisms associated with acute GVHD.

    abstract::Candidate genetic associations with acute GVHD (aGVHD) were evaluated with the use of genotyped and imputed single-nucleotide polymorphism data from genome-wide scans of 1298 allogeneic hematopoietic cell transplantation (HCT) donors and recipients. Of 40 previously reported candidate SNPs, 6 were successfully genotyp...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验,评审

    doi:10.1182/blood-2011-09-371153

    authors: Chien JW,Zhang XC,Fan W,Wang H,Zhao LP,Martin PJ,Storer BE,Boeckh M,Warren EH,Hansen JA

    更新日期:2012-05-31 00:00:00

  • Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion.

    abstract::Multiple mechanisms operate to ensure T-cell tolerance toward self-antigens. Three main processes have been described: clonal deletion, anergy, and deviation to CD4(+) regulatory T cells (Tregs) that suppress autoreactive T cells that have escaped the first 2 mechanisms. Although it is accepted that dendritic cells (D...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-336115

    authors: Morlacchi S,Soldani C,Viola A,Sarukhan A

    更新日期:2011-07-28 00:00:00

  • Speaking a common language in MDS/MPNs.

    abstract::In this issue of Blood, Savona and an international consortium of clinical investigators propose uniform response criteria for treatment trials enrolling adult patients with myelodysplastic/myeloproliferative neoplasms (MDS/MPNs). Such a proposal is needed because new drugs are finally being tested in these rare “over...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-02-626473

    authors: Steensma DP

    更新日期:2015-03-19 00:00:00

  • Fetal erythropoiesis following bone marrow transplantation.

    abstract::"Fetal" erythrocytes are present in older children and certain adults with hematologic disorders. To determine if regenerating bone marrow produces such cells, we examined the blood of seven allogeneic bone marrow transplant recipients. Six patients were engrafted with donor cells, while on e patients recovered autolo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Alter BP,Rappeport JM,Huisman TH,Schroeder WA,Nathan DG

    更新日期:1976-12-01 00:00:00

  • How I treat acquired aplastic anemia.

    abstract::Survival in severe aplastic anemia (SAA) has markedly improved in the past 4 decades because of advances in hematopoietic stem cell transplantation, immunosuppressive biologics and drugs, and supportive care. However, management of SAA patients remains challenging, both acutely in addressing the immediate consequences...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-12-274019

    authors: Scheinberg P,Young NS

    更新日期:2012-08-09 00:00:00

  • Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model.

    abstract::Primary graft rejection after marrow transplantation occurs more frequently in patients receiving HLA-haploidentical compared with HLA-identical sibling transplants. Both human and experimental animal data suggest that the cells responsible for this phenomenon are either host natural killer (NK) cells, T cells, or bot...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sandmaier BM,Storb R,Bennett KL,Appelbaum FR,Santos EB

    更新日期:1998-05-01 00:00:00

  • In vitro identification of single CD34+CD38- cells with both lymphoid and myeloid potential.

    abstract::Human hematopoietic stem cells are pluripotent, ie, capable of producing both lymphoid and myeloid progeny, and are therefore used for transplantation and gene therapy. An in vitro culture system was developed to study the multi-lineage developmental potential of a candidate human hematopoietic stem cell population, C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hao QL,Smogorzewska EM,Barsky LW,Crooks GM

    更新日期:1998-06-01 00:00:00

  • B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.

    abstract::Antigenic stimulation through the B-cell antigen receptor (BCR) is considered to promote the expansion of chronic lymphocytic leukemia (CLL) B cells. The spleen tyrosine kinase (Syk), a key component of BCR signaling, can be blocked by R406, a small-molecule Syk inhibitor, that displayed activity in CLL patients in a ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-212837

    authors: Quiroga MP,Balakrishnan K,Kurtova AV,Sivina M,Keating MJ,Wierda WG,Gandhi V,Burger JA

    更新日期:2009-07-30 00:00:00

  • Memory CD4(+)CCR5(+) T cells are abundantly present in the gut of newborn infants to facilitate mother-to-child transmission of HIV-1.

    abstract::Despite potential clinical importance, target cells for mother-to-child transmission of HIV-1 have not yet been identified. Cord blood-derived CD4(+) T cells are largely naive and do not express CCR5, the mandatory coreceptor for transmitted HIV-1 R5 strains in infants. In the present study, we demonstrate that in the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-437566

    authors: Bunders MJ,van der Loos CM,Klarenbeek PL,van Hamme JL,Boer K,Wilde JC,de Vries N,van Lier RA,Kootstra N,Pals ST,Kuijpers TW

    更新日期:2012-11-22 00:00:00

  • CYLD regulates angiogenesis by mediating vascular endothelial cell migration.

    abstract::Cylindromatosis (CYLD) is a deubiquitinase that was initially identified as a tumor suppressor and has recently been implicated in diverse normal physiologic processes. In this study, we have investigated the involvement of CYLD in angiogenesis, the formation of new blood vessels from preexisting ones. We find that kn...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-10-248526

    authors: Gao J,Sun L,Huo L,Liu M,Li D,Zhou J

    更新日期:2010-05-20 00:00:00

  • alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.

    abstract::The Aalpha-fibrinogen Thr312Ala polymorphism, which occurs in a region involved in factor XIII (FXIII)-dependent cross-linking processes, is associated with poststroke mortality in subjects with atrial fibrillation, suggesting an influence either on intraatrial clot formation or embolization. We have determined the as...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Carter AM,Catto AJ,Kohler HP,Ariëns RA,Stickland MH,Grant PJ

    更新日期:2000-08-01 00:00:00

  • Therapeutic targeting of HES1 transcriptional programs in T-ALL.

    abstract::Oncogenic activation of NOTCH1 signaling plays a central role in the pathogenesis of T-cell acute lymphoblastic leukemia, with mutations on this signaling pathway affecting more than 60% of patients at diagnosis. However, the transcriptional regulatory circuitries driving T-cell transformation downstream of NOTCH1 rem...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-10-608448

    authors: Schnell SA,Ambesi-Impiombato A,Sanchez-Martin M,Belver L,Xu L,Qin Y,Kageyama R,Ferrando AA

    更新日期:2015-04-30 00:00:00

  • Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease.

    abstract::Graft-versus-host disease (GVHD), a life-threatening complication after allogeneic hematopoietic stem cell transplantation, is caused by alloreactive donor T cells that trigger host tissue damage. The inflammatory environment inside recipients is critical for GVHD pathogenesis, but the underpinning mechanisms remain e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-281659

    authors: Zhao F,Zhang Y,Wang H,Jin M,He S,Shi Y,Guo Y,Zhang Y

    更新日期:2011-02-03 00:00:00

  • Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation.

    abstract::Donor lymphocyte infusion (DLI) can restore durable molecular remission in a high percentage of patients with chronic myeloid leukemia (CML) who have relapses after allogeneic stem cell transplantation, but for patients who do not respond survival is poor. Imatinib mesylate (STI571) is a specific inhibitor of BCR-ABL ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.10.3861

    authors: Olavarria E,Craddock C,Dazzi F,Marin D,Marktel S,Apperley JF,Goldman JM

    更新日期:2002-05-15 00:00:00

  • Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages.

    abstract::The differentiation of human peripheral blood monocytes into resident macrophages is driven by colony-stimulating factor-1 (CSF-1), which upon interaction with CSF-1 receptor (CSF-1R) induces within minutes the phosphorylation of its cytoplasmic tyrosine residues and the activation of multiple signaling complexes. Cas...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-208843

    authors: Jacquel A,Benikhlef N,Paggetti J,Lalaoui N,Guery L,Dufour EK,Ciudad M,Racoeur C,Micheau O,Delva L,Droin N,Solary E

    更新日期:2009-10-22 00:00:00

  • Erythropoiesis-stimulating factor production by rabbit kidney cultures from "programmed" rabbits.

    abstract::Rabbit kidney tissue either from normal rabbits or from rabbits "programmed" by phlebotomy or varying periods of hypoxia was cultured and shown to release into the culture medium an erythropoietically active substance. The cultures established from rabbits programmed by 6-12 hr of hypoxia yielded the highest levels of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ogle JW,Lange RD,Dunn CD

    更新日期:1978-07-01 00:00:00

  • Liposomal ET-18-OCH(3) induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling.

    abstract::ELL-12, a liposome formulation of the ether-lipid 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (ET-18-OCH(3)), is a nonmyelosuppressive antiproliferative agent that is more effective and less toxic than the ether lipid itself in tumor model systems. We found that ELL-12 induced apoptosis in Jurkat, H9, and U-9...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cuvillier O,Mayhew E,Janoff AS,Spiegel S

    更新日期:1999-11-15 00:00:00

  • Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome.

    abstract::Venous limb gangrene (VLG) can occur in cancer patients, but the clinical picture and pathogenesis remain uncertain. We identified 10 patients with metastatic cancer (7 pathologically proven) who developed severe venous limb ischemia (phlegmasia/VLG) after initiating treatment of deep-vein thrombosis (DVT); in 8 patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-622787

    authors: Warkentin TE,Cook RJ,Sarode R,Sloane DA,Crowther MA

    更新日期:2015-07-23 00:00:00

  • Expression and downregulation of cytotoxic cell protease 1 or Granzyme 'B' transcripts during myeloid differentiation of interleukin-3-dependent murine stem cell lines.

    abstract::Using the technique of differential cDNA library screening, we have molecularly cloned a gene that is highly expressed in an undifferentiated myeloid multipotent and growth factor-dependent stem cell line (FDCP-Mix) and that downregulates as these cells are induced to differentiate along monocytic, granulocytic, and e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hampson IN,Cross MA,Heyworth CM,Fairbairn L,Spooncer E,Cowling GJ,Dexter TM

    更新日期:1992-12-15 00:00:00

  • An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals.

    abstract::IL-17 and its receptor are founding members of a novel family of inflammatory cytokines. IL-17 plays a pathogenic role in rheumatoid arthritis (RA)-associated bone destruction. However, IL-17 is also an important regulator of host defense through granulopoiesis and neutrophil trafficking. Therefore, the role of IL-17 ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-09-010116

    authors: Yu JJ,Ruddy MJ,Wong GC,Sfintescu C,Baker PJ,Smith JB,Evans RT,Gaffen SL

    更新日期:2007-05-01 00:00:00

  • The active monomeric form of macrophage inflammatory protein-1 alpha interacts with high- and low-affinity classes of receptors on human hematopoietic cells.

    abstract::Macrophage inflammatory protein-1 alpha (MIP-1 alpha) and its human homologue GOS19.1/LD78 are members of the C-C chemokine/intercrine family of secreted proteins. They have proinflammatory properties and also inhibit cell cycle progression of hematopoietic stem cells. Characterization of MIP-1 alpha receptor(s) has b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Avalos BR,Bartynski KJ,Elder PJ,Kotur MS,Burton WG,Wilkie NM

    更新日期:1994-09-15 00:00:00

  • Inactivation of the ATM gene in T-cell prolymphocytic leukemias.

    abstract::T-cell prolymphocytic leukemia (T-PLL) is a rare form of mature leukemia that occurs both in adults as a sporadic disease and in younger patients suffering an hereditary condition, ataxia telangiectasia (AT). The ATM gene, located in the 11q22-23 chromosomal region, is consistently mutated in AT patients. The strong p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stoppa-Lyonnet D,Soulier J,Laugé A,Dastot H,Garand R,Sigaux F,Stern MH

    更新日期:1998-05-15 00:00:00

  • Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5.

    abstract::We used synthetic peptides to the extracellular loops (ECLs) of CCR5 to examine inhibitory effects on HIV infection/fusion with primary leukocytes and cells expressing recombinant CCR5. We show for the first time that peptides derived from the first, second, or third ECL caused dose-dependent inhibition of fusion and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2669

    authors: Agrawal L,VanHorn-Ali Z,Berger EA,Alkhatib G

    更新日期:2004-02-15 00:00:00

  • Vav proteins regulate peripheral B-cell survival.

    abstract::Mice lacking all 3 Vav proteins fail to produce significant numbers of recirculating follicular or marginal zone B cells. Those B cells that do mature have shortened lifespans. The constitutive nuclear factor-kappaB (NF-kappaB) activity of resting naive B cells required Vav function and expression of cellular reticulo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4894

    authors: Vigorito E,Gambardella L,Colucci F,McAdam S,Turner M

    更新日期:2005-10-01 00:00:00

  • Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor.

    abstract::Human natural killer (NK) cell development is a step-by-step process characterized by phenotypically identified stages. CD161 is a marker informative of the NK cell lineage commitment, whereas CD56, CD117, and CD94/NKG2A contribute to define discrete differentiation stages. In cells undergoing in vitro differentiation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-09-379693

    authors: Montaldo E,Vitale C,Cottalasso F,Conte R,Glatzer T,Ambrosini P,Moretta L,Mingari MC

    更新日期:2012-04-26 00:00:00

  • Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma.

    abstract::Proteasome inhibition is an effective treatment strategy for multiple myeloma. With improving survival, attention is increasingly focusing on ease of administration and toxicity profile. Ixazomib is an investigational, orally bioavailable 20S proteasome inhibitor. Sixty patients with relapsed and/or refractory multipl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-01-548941

    authors: Kumar SK,Bensinger WI,Zimmerman TM,Reeder CB,Berenson JR,Berg D,Hui AM,Gupta N,Di Bacco A,Yu J,Shou Y,Niesvizky R

    更新日期:2014-08-14 00:00:00

  • Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.

    abstract::The number of CD34+ cells in the peripheral blood of cancer patients is known to be increased following the administration of high dose chemotherapy and hematopoietic growth factors. These so-called peripheral blood stem cell grafts are now frequently used for autologous transplantation of patients with malignancies. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Murray L,Chen B,Galy A,Chen S,Tushinski R,Uchida N,Negrin R,Tricot G,Jagannath S,Vesole D

    更新日期:1995-01-15 00:00:00